Regulation of HDM2 activity by the ribosomal protein L11

Cancer Cell

Volumn 3, Issue 6, 2003, Pages 577-587

  Lohrum, Marion A E ^a   Ludwig, Robert L ^a,b   Kubbutat, Michael H G ^a,c   Hanlon, Mary ^a   Vousden, Karen H ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^c PROQINASE GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; DACTINOMYCIN; HUMAN DOUBLE MINUTE 2 PROTEIN; PROTEIN; PROTEIN P53; RIBOSOME PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REGULATORY MECHANISM;

ANIMALIA;

EID: 0038724615     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(03)00134-X     Document Type: Article

References (74)

1. Ashcroft M., Taya Y., Vousden K.H. Stress signals utilize multiple pathways to stabilize p53. Mol. Cell. Biol. 20:2000;3224-3233.
2. Barak Y., Juven T., Haffner R., Oren M. Mdm-2 expression is induced by wild type p53 activity. EMBO J. 12:1993;461-468.
3. Waf1/Cip1 expression. Oncogene. 17:1998;1691-1703.
4. Blattner C., Hay T., Meek D.W., Lane D.P. Hypophosphorylation of Mdm2 augments p53 stability. Mol. Cell. Biol. 22:2002;6170-6182.
5. Boon K., Caron H.N., van Asperen R., Valentijn L., Hermis M.-C., van Sluis P., Roobeek I., Weis I., Voûte P.A., Schwab M., Versteeg R. N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. EMBO J. 20:2001;1383-1393.
6. Bothner B., Lewis W.S., DiGiammarino E.L., Weber J.D., Bothner S.J., Kriwacki R.W. Defining the molecular basis of Arf and Hdm2 interactions. J. Mol. Biol. 314:2001;263-277.
7. Boyd S.D., Tsai K.Y., Jacks T. An intact HDM2.RING-finger domain is required for nuclear exclusion of p53. Nat. Cell Biol. 2:2000;563-568.
8. Buschmann T., Potapova O., Bar-Shira A., Ivanov V.N., Fuchs S.Y., Henderson S., Fried V.A., Minamoto T., Alarcon-Vargas D., Pincus M.et al. Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress. Mol. Cell. Biol. 21:2001;2743-2754.
9. Chehab N.H., Malikzay A., Appel M., Halazonetis T.D. Chk2/hCds1 functions as a DNA damage checkpoint in G1 by stabilizing p53. Genes Dev. 14:2000;278-288.
10. Chen D., Huang S. Nucleolar components involved in ribosome biogenesis cycle between the nucleolus and nucleoplasm in interphase cells. J. Cell Biol. 153:2001;169-176.
11. Chen F.W., Ioannou Y.A. Ribosomal proteins in cell proliferation and apoptosis. Int. Rev. Immunol. 18:1999;429-448.
12. Chen J., Lin J., Levine A.J. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene. Mol. Med. 1:1995;142-152.
13. de Rozieres S., Maya R., Oren M., Lozano G. The loss of mdm2 induces p53 mediated apoptosis. Oncogene. 19:2000;1691-1697.
14. Fakharzadeh S.S., Trusko S.P., George D.L. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J. 10:1991;1565-1569.
15. Fang S., Jensen J.P., Ludwig R.L., Vousden K.H., Weissman A.M. Ubiquitin protein ligase activity of Mdm2. differential RING finger requirements for ubiquitination and proteasomal targeting of Mdm2 and p53 J. Biol. Chem. 275:2000;8945-8951.
16. Fields S., Song O. A novel genetic system to detect protein-protein interactions. Nature. 340:1989;245-246.
17. Geyer R.K., Yu Z.K., Maki C.G. The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat. Cell Biol. 2:2000;569-573.
18. Goldberg Z., Vogt Sionov R., Berger M., Zwang Y., Perets R., Van Etten R.A., Oren M., Taya Y., Haupt Y. Tyrosine phosphorylation of Mdm2 by c-Abl. implications for p53 regulation EMBO J. 21:2002;3715-3727.
19. Gu J., Nie N., Wiederschain D., Yuan Z.-M. Identification of p53 sequence elements that are required for MDM2-mediated nuclear export. Mol. Cell. Biol. 21:2001;8533-8546.
20. Handa H., Kobayashi-Uehara A., Murayama S. Characterization of a wheat cDNA encoding mitochondrial ribosomal protein L11. qualitative and quantitative tissue-specific differences in its expression Mol. Genet. Genomics. 265:2001;569-575.
21. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 387:1997;296-299.
22. Hirao A., Kong Y.Y., Matsuoka S., Wakeham A., Ruland J., Yoshida H., Liu D., Elledge S.J., Mak T.W. DNA damage-inducible activation of p53 by the checkpoint kinase Chk2. Science. 287:2000;1824-1827.
23. ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 18:1999;22-27.
24. Honda R., Tanaka H., Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420:1997;25-27.
25. Iordanov M.S., Pribnow D., Magun J.L., Dinh T.-H., Pearson J.A., Magun B.E. Ultraviolet radiation triggers the ribotoxic stress response in mammalian cells. J. Biol. Chem. 273:1998;15794-15803.
26. Jones S.N., Roe A.E., Donehower L.A., Bradley A. Rescue of embyonic lethality in Mdm2-deficient mice by absence of p53. Nature. 378:1995;206-208.
27. Khan S.H., Moritsugu J., Wahl G.M. Differential requirement for p19ARF in the p53-depedent arrest induced by DNA damage, microtubule disruption, and ribonucleotide depletion. Proc. Natl. Acad. Sci. USA. 97:2000;3266-3271.
28. Korgaonkar C., Zhao L., Modestou M., Quelle D.E. ARF function does not require p53 stabilization of Mdm2 relocalization. Mol. Cell. Biol. 22:2002;196-206.
29. Kressler D., Linder P., de la Cruz J. Protein trans-acting factors involved in ribosome biogenesis in Saccaromyces cerevisiae. Mol. Cell. Biol. 19:1999;7897-7912.
30. Kubbutat M.H.G., Jones S.N., Vousden K.H. Regulation of p53 stability by Mdm2. Nature. 387:1997;299-303.
31. Kubbutat M.H.G., Ludwig R.L., Levine A.J., Vousden K.H. Analysis of the degradation function of Mdm2. Cell Growth and Differ. 10:1999;87-92.
32. Leary D.J., Huang S. Regulation of ribsome biogenesis within the nucleolus. FEBS Lett. 509:2001;145-150.
33. Leng R.P., Lin Y., Ma W., Wu H., Lemmers B., Chung S., Parant J.M., Lozano G., Hakem R., Benchimol S. Pirh2, a p53-inducible ubiquitin-protein ligase, promotes p53 degradation. Cell. 112:2003;779-791.
34. Ljungman M., O'Hagan H.M., Paulsen M.T. Induction of ser15 and lys382 modifications of p53 by blockage of transcriptional elongation. Oncogene. 20:2001;5964-5971.
35. Llanos S., Clark P.A., Rowe J., Peters G. Stabilization of p53 by p14ARF without relocalization of MDM2 to the nucleolus. Nat. Cell Biol. 3:2001;445-452.
36. Lohrum M.A.E., Ashcroft M., Kubbutat M.H.G., Vousden K.H. Identification of a cryptic nucleolar localization signal in MDM2. Nat. Cell Biol. 2:2000;179-181.
37. Lohrum M.A.E., Woods D.B., Ludwig R.L., Bálint E., Vousden K.H. C-terminal ubiquitination of p53 contributes to nuclear export. Mol. Cell. Biol. 21:2001;8521-8532.
38. Maden B.E., Vaughan M.H., Warner J.R., Darnell J.E. Effects of valine deprivation on ribosome formation in HeLa cells. J. Mol. Biol. 45:1969;265-275.
39. Marechal V., Elenbaas B., Piette J., Nicolas J.-C., Levine A.J. The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol. Cell. Biol. 14:1994;7414-7420.
40. Marston N.J., Crook T., Vousden K.H. Interaction of p53 with MDM2 is independent of E6 and does not mediate wild type transformation suppressor function. Oncogene. 9:1994;2707-2716.
41. Maya R., Balass M., Kim S.T., Shkedy D., Leal J.F., Shifman O., Moas M., Buschmann T., Ronai Z., Shiloh Y.et al. ATM-dependent phosphorylation of Mdm2 on serine 395. role in p53 activation by DNA damage Genes Dev. 15:2001;1067-1077.
42. Midgley C.A., Desterro J.M., Saville M.K., Howard S., Sparks A., Hay R.T., Lane D.P. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene. 19:2000;2312-2323.
43. Momand J., Zambetti G.P., George D.L., Levine A.J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell. 69:1992;1237-1245.
44. Montes de Oca Luna R., Wagner D.S., Lozano G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature. 378:1995;203-206.
45. Nelson W.G., Kastan M.B. DNA strand breaks. the DNA template alterations that trigger p53-dependent DNA damage response pathways Mol. Cell. Biol. 14:1994;1815-1823.
46. Oliner J.D., Kinzler K.W., Meltzer P.S., George D.L., Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature. 358:1992;80-83.
47. Oliner J.D., Pietenpol J.A., Thiagalingam S., Gyuris J., Kinzler K.W., Vogelstein B. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature. 362:1993;857-860.
48. Pederson T., Kumar A. Relationship between protein synthesis and ribosome assembly in HeLa cells. J. Mol. Biol. 61:1971;655-668.
49. Perry R.P., Kelley D.E. Inhibition of RNA synthesis by actinomycin D. characteristic dose-response of different RNA species J. Cell. Physiol. 76:1970;127-140.
50. Pestov D.G., Strezoska Z., Lau L.F. Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle. effects of nucleolar protein Bop1 on G1/S transition Mol. Cell. Biol. 21:2001;4246-4255.
51. Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell. 92:1998;713-723.
52. Rizos H., Darmanian A.P., Mann G.J., Kefford R.F. Two arginine rich domains in the p14ARF tumor suppressor mediate nucleolar translocation. Oncogene. 19:2000;2978-2985.
53. Rowan S., Ludwig R.L., Haupt Y., Bates S., Lu X., Oren M., Vousden K.H. Specific loss of apoptotic but not cell cycle arrest function in a human tumour derived p53 mutant. EMBO J. 15:1996;827-838.
54. Ryan K.M., Phillips A.C., Vousden K.H. Regulation and function of the p53 tumor suppressor protein. Curr. Biol. 13:2001;332-337.
55. Sherr C.J., Weber J.D. The ARF/p53 pathway. Curr. Opin. Genet. Dev. 10:2000;94-99.
56. Shieh S.-Y., Ahn J., Tamai K., Taya Y., Prives C. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. Genes Dev. 14:2000;289-300.
57. Shiio Y., Donohoe S., Yi E.C., Goodlett D.R., Aebersold R., Eisenman R.N. Quantitative proteomic analysis of Myc oncoprotein function. EMBO J. 21:2002;5088-5096.
58. Snyder A.L., Kann H.E.J., Kohn K.W. Inhibition of the processing of ribosomal precursor RNA by intercalating agents. J. Mol. Biol. 58:1971;5516-5528.
59. ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17:1998;5001-5014.
60. Sugimoto M., Kuo M.-L., Roussel M.F., Sherr C.J. Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. Mol. Cell. 11:2003;415-424.
61. Vousden K.H. Regulation of the cell cycle by viral oncoproteins. Semin. Cancer Biol. 6:1995;109-116.
62. Vousden K.H. p53. death star Cell. 101:2000;691-694.
63. Vousden K.H., Lu X. Live or let die. the cell's response to p53 Nat. Rev. Cancer. 2:2002;594-604.
64. Wadgaonkar R., Collins T. Murine double minute (MDM2) blocks p53-coactivator interaction, a new mechanisms for inhibition of p53-dependent gene expression. J. Biol. Chem. 274:1999;13760-13767.
65. Weber J.D., Taylor L.J., Roussel M.F., Sherr C.J., Bar-Sagi D. Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell Biol. 1:1999;20-26.
66. Weber J.D., Kuo M.-L., Bothner B., DiGiammarino E.L., Kriwacki R.W., Roussel M.F., Sherr C.J. Cooperative signals governing the ARF-Mdm2 interaction and nucleolar localization of the complex. Mol. Cell. Biol. 20:2000;2517-2528.
67. Woods D.B., Vousden K.H. Regulation of p53 function. Exp. Cell Res. 264:2001;56-66.
68. Wu X.W., Bayle J.H., Olson D., Levine A.J. The p53 mdm-2 autoregulatory feedback loop. Genes Dev. 7:1993;1126-1132.
69. Xirodimas D.P., Saville M.K., Edling C., Lane D.P., Lain S. Differential effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo. Oncogene. 20:2001;4972-4983.
70. Yokoyama Y., Niwa K., Tamaya T. Scattering of the silver-stained proteins of nuycleolar organizer regions in Ishikawa cells by actinomycin D. Exp. Cell Res. 202:1992;77-86.
71. Zhai W., Comai L. Repression of RNA polymerase I transcription by the tumor suppresor p53. Mol. Cell. Biol. 20:2000;5930-5938.
72. Zhang Y., Xiong Y., Yarbrough W.G. ARF promotes MDM2 degradation and stabilizes p53. ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways Cell. 92:1998;725-734.
73. Zhang S., Scott J.M., Haldenwang W.G. Loss of ribosomal protein L11 blocks stress activation of the Bacillus subtilis transcription factor sigma (B). J. Bacteriol. 183:2001;2316-2321.
74. Zhu L., Vandenheuvel S., Helin K., Fattaey A., Ewen M., Livingston D., Dyson N., Harlow E. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7:1993;1111-1125.